Remove Develop Remove Equity Remove Funding Remove Silver Lake
article thumbnail

Cornerstone OnDemand Raises $300M From Silver Lake

socalTECH

Santa Monica-based enterprise software developer Cornerstone OnDemand has raised $300M in a strategic investment from private equity investor Silver Lake, according to the company. Cornerstone OnDemand is a developer of human capital and talent management software. READ MORE>>.

article thumbnail

Kareo Adds $55M In Funding

socalTECH

Irvine-based Kareo , the developer of cloud-based software used to manage medical practices, said this morning that it has raised $55.4M in a new funding round. The funding was led by Montreux Equity Partners, and also included Silver Lake Partners and the company's existing investors. READ MORE>>.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tealium Gets $20M More For Tag Management

socalTECH

San Diego-based tag management software developer Tealium announced this morning that it has raised an additional $20M in funding, from private equity investor Silver Lake Waterman. Tealium, which is led by Jeff Lunsford, said it plans to use the funding for global expansion. READ MORE>>.

article thumbnail

Shea Ventures Backs SolarCity

socalTECH

Shea Ventures , the venture capital arm of Orange County homebuilder Shea Homes , has boosted its solar installation partner SolarCity , as part of an $81M equity investment in SolarCity. According to SolarCity, the big funding round was led by The round was led by Silver Lake Kraftwerk and Valor Equity Partners, and also included Nicholas J.

article thumbnail

Power-One Gets $60M Injection

socalTECH

Camarillo-based Power-One , a developer of power supplies and related products, said late Thursady that the firm has agreed to a $60M investment from investment firm Silver Lake Sumeru. The firm said it will use the funding to restructure its debt, plus for working capital and strategic initiatives.

article thumbnail

Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More

Xconomy

In 2018, my Exome colleagues and I published hundreds of stories about health, medicine, the biopharma industry, government policy, and more. You’ll find a few of our favorite stories in this review of some of the year’s best from across the Xconomy network.

Pricing 69